Exhibit 4.8 

   

    

  
    DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO

    SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

    

    

    DESCRIPTION OF CAPITAL STOCK

    

    

    The following summary of the general terms and provisions of the registered capital stock of Rocket Pharmaceuticals, Inc. (“Rocket”, “we”, “our”) does not
      purport to be complete and is subject to, and qualified in its entirety by, reference to our Seventh Amended and Restated Certificate of Incorporation (“certificate of incorporation”) our Amended and Restated Bylaws (“bylaws”) each of which is
      incorporated by reference as an exhibit to our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, and applicable provisions of the Delaware General Corporation Law (the “DGCL”). Our common stock, par value $0.01
      per share is registered pursuant to Section 12(b) of the Securities and Exchange Act of 1934 and trades on the Nasdaq Global Market under the symbol RCKT. The summaries below do not purport to be complete statements of the relevant provisions of the
      certificate of incorporation, the bylaws or the DGCL.

    

    

    Authorized Capital Stock

    

    

    Our authorized capital stock consists of 120,000,000 shares of common stock, par value $0.01 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share,
      all of which shares of preferred stock are undesignated.

    

    

    Common Stock

    

    

    The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock
        do not have any cumulative voting rights. Holders of our common stock are entitled to receive dividends, if any, as and when may be declared from time to time by our board of directors out of funds legally available for that purpose, subject to any
        preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions.

    

    

    Upon liquidation, dissolution or winding up of our affairs, the holders of common stock will be entitled to participate equally and ratably, in proportion to the
        number of shares held, in our net assets available for distribution to holders of common stock.

    

    

    Stock Exchange Listing

    

    

    Our common stock is listed on the NASDAQ Global Market. The trading symbol for our common stock is “RCKT.”

    

    

    Transfer Agent and Registrar

    

    

    The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company. The transfer agent and registrar’s address is 1 State Street, New
      York, NY 10004.

    

    

    Undesignated Preferred Stock

    

    

    Our board of directors is authorized, without further action by the stockholders, to designate and issue up to an aggregate of 5,000,000 shares of preferred stock in one or
      more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund
      terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common stock. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights
      that could adversely affect the voting power or other rights of the holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation.

    

    

    
      
        


    

    The purpose of authorizing our board of directors to issue preferred stock in one or more series and determine the number of shares in the series and its rights,
      preferences, privileges and restrictions is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible future financings and acquisitions and
      other corporate purposes could, under certain circumstances, have the effect of delaying, deferring or preventing a change in control of our company or other corporate action.

    

    

    Certain Provisions of Our Certificate of Incorporation and Bylaws; Director Indemnification Agreements

    

    

    Our Board of Directors

    

    

    Our certificate of incorporation provides for the annual election of directors. At each annual meeting of stockholders, directors elected to succeed those directors whose
      terms expire shall be elected for a term of office to expire at the next annual meeting of stockholders after their election. The number of directors may be fixed exclusively by resolution duly adopted from time to time by the Board of Directors.
      Directors may be removed from office, with or without cause, only by the affirmative vote of a majority of the outstanding shares of capital stock then entitled to vote thereon.

    

    

    Special Meetings

    

    

    Our certificate of incorporation and by-laws provide that a majority of the members of our Board of Directors then in office may call special meetings of stockholders and
      only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our by-laws limit the business that may be conducted at an annual meeting of stockholders to those matters
      properly brought before the meeting. Our by-laws also establish the right for stockholders who collectively own at least 20 percent of the outstanding shares of common stock of the Company to call a special meeting of the stockholders, subject to the
      procedural and other requirements set forth in the by-laws, and to require that a timely notice also include a representation that a proposing stockholder (or a qualified representative of the stockholder) intends to appear at the stockholder meeting
      to make any director nomination or propose any such other business to be presented at the special meeting.

    

    

    Indemnification

    

    

    Our certificate of incorporation and our by-laws, as amended, provide that we shall indemnify our directors and officers to the fullest extent permitted by law. In
      addition, we have previously entered into and intend to enter into new agreements to indemnify our directors and executive officers. These agreements will, among other things, indemnify these individuals for certain expenses (including attorneys’
      fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our right, on account of any services undertaken by such person on behalf of us or that person’s status as a
      member of our Board of Directors.

    

    

    
      
        


    

    Section 203 of the Delaware General Corporation Law

    

    

    We are subject to the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business
      combination” with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section 203, a business
      combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:

    

    

    	

          	•	
            before the stockholder became interested, our Board of Directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested
              stockholder;

          


    

    

    	

          	•	
            upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the
              corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances, but
              not the outstanding voting stock owned by the interested stockholder; or

          


    

    

    	

          	•	
            at or after the time the stockholder became interested, the business combination was approved by our Board of Directors and authorized at an annual or special meeting of the
              stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.

          


    

    

    Section 203 defines a business combination to include:

    

    

    	

          	•	
            any merger or consolidation involving the corporation and the interested stockholder;

          


    

    

    	

          	•	
            any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;

          


    

    

    	

          	•	
            subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

          


    

    

    	

          	•	
            subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation
              beneficially owned by the interested stockholder; and

          


    

    

    	

          	•	
            the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

          


    

    

    In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any
      entity or person affiliated with or controlling or controlled by the entity or person.